Clinical Trial Update: Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial update for maintenance lurbinectedin in combination with serplulimab in extensive-stage small cell lung cancer; the study is currently not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Serplulimab (serplulimab)
• Zepzelca (lurbinectedin)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Extensive-Stage Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING